Cite
MLA Citation
Nobuhisa Hagiwara et al.. “Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.” Cancer letters, vol. 431, 2018, pp. 182–189. http://access.bl.uk/ark:/81055/vdc_100066429523.0x000037